• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺动脉栓塞术有效治疗巨大前列腺增生所致顽固性血尿

Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization.

作者信息

Kably Issam, Bode Alexander

机构信息

Jackson Memorial Hospital, Department of Vascular and Interventional Radiology (R-109), PO Box 016960, Miami, FL, USA.

University of Miami Leonard M. Miller School of Medicine, 1600 NW 10th Ave #1140, Miami, FL, USA.

出版信息

Asian J Urol. 2020 Jul;7(3):318-321. doi: 10.1016/j.ajur.2019.06.002. Epub 2019 Jun 22.

DOI:10.1016/j.ajur.2019.06.002
PMID:32742932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7385503/
Abstract

Giant prostatic hyperplasia (GPH) is a rare pathology traditionally treated with an open suprapubic prostatectomy. This procedure is risky, and fatal hemorrhagic complications can occur. Often, patients with GPH present with diminished renal function due to obstructive nephropathy, making them unfit for less invasive endovascular therapies using traditional contrast agents. Here we present a case of a patient with intractable hematuria due to GPH, as well as diminished renal function, who was successfully treated using prostatic artery embolization with CO digital subtraction arteriography as a contrast agent.

摘要

巨大前列腺增生(GPH)是一种罕见的病理情况,传统上采用耻骨上开放性前列腺切除术进行治疗。该手术风险较大,可能会出现致命的出血并发症。通常,GPH患者由于梗阻性肾病导致肾功能减退,使其不适用于使用传统造影剂的侵入性较小的血管内治疗。在此,我们介绍一例因GPH导致顽固性血尿且肾功能减退的患者,该患者使用CO数字减影血管造影作为造影剂进行前列腺动脉栓塞术,成功得到治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db7/7385503/a86d5d4894ea/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db7/7385503/eb7041bb918c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db7/7385503/ce5c868f9898/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db7/7385503/d16739d23f10/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db7/7385503/a86d5d4894ea/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db7/7385503/eb7041bb918c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db7/7385503/ce5c868f9898/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db7/7385503/d16739d23f10/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5db7/7385503/a86d5d4894ea/gr4.jpg

相似文献

1
Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization.前列腺动脉栓塞术有效治疗巨大前列腺增生所致顽固性血尿
Asian J Urol. 2020 Jul;7(3):318-321. doi: 10.1016/j.ajur.2019.06.002. Epub 2019 Jun 22.
2
[Giant prostatic hyperplasia: a case report and review of the literature].
Zhonghua Nan Ke Xue. 2011 Feb;17(2):151-5.
3
Management of a giant prostatic enlargement: Case report and review of the literature.巨大前列腺增生的管理:病例报告及文献综述
Niger Postgrad Med J. 2020 Jul-Sep;27(3):242-247. doi: 10.4103/npmj.npmj_69_20.
4
Giant Prostatic Hyperplasia: Fourth largest prostate reported in medical literature.巨大前列腺增生:医学文献报道的第四大前列腺病例。
Sultan Qaboos Univ Med J. 2014 May;14(2):e253-6. Epub 2014 Apr 7.
5
Giant prostatic hyperplasia: report of a previously asymptomatic man presenting with gross hematuria and hypovolemic shock.巨大前列腺增生症:一例既往无症状男性出现肉眼血尿和低血容量性休克的报告。
Einstein (Sao Paulo). 2015 Jul-Sep;13(3):420-2. doi: 10.1590/S1679-45082015RC2905. Epub 2015 Jun 30.
6
A case of giant prostatic hyperplasia.一例巨大前列腺增生症。
Asian J Urol. 2016 Jan;3(1):53-55. doi: 10.1016/j.ajur.2015.10.004. Epub 2015 Nov 3.
7
Role of prostate artery embolization in the management of refractory haematuria of prostatic origin.前列腺动脉栓塞术在治疗前列腺源性难治性血尿中的作用。
BJU Int. 2016 Sep;118(3):359-65. doi: 10.1111/bju.13524. Epub 2016 Jun 13.
8
Persistent prostatic hematuria.持续性前列腺血尿。
Nat Clin Pract Urol. 2008 Mar;5(3):159-65. doi: 10.1038/ncpuro1044.
9
Clinically intractable chronic unilateral hematuria: Successful treatment with renal segmental artery embolization.临床难治性慢性单侧血尿:肾段动脉栓塞术治疗成功
Minim Invasive Ther Allied Technol. 2018 Aug;27(4):242-245. doi: 10.1080/13645706.2017.1407343. Epub 2017 Nov 23.
10
Prostatic Artery Embolization in Nonindex Benign Prostatic Hyperplasia Patients: Single-center Outcomes for Urinary Retention and Gross Prostatic Hematuria.非指征性良性前列腺增生患者的前列腺动脉栓塞术:尿潴留和前列腺大出血的单中心结局。
Urology. 2020 Feb;136:212-217. doi: 10.1016/j.urology.2019.11.003. Epub 2019 Nov 14.

本文引用的文献

1
Prostate Artery Embolization (PAE) in the Management of Refractory Hematuria of Prostatic Origin Secondary to Iatrogenic Urological Trauma: A Safe and Effective Technique.前列腺动脉栓塞术(PAE)治疗医源性泌尿系统创伤继发的前列腺源性难治性血尿:一种安全有效的技术
Urology. 2016 Feb;88:218-21. doi: 10.1016/j.urology.2015.10.025. Epub 2015 Nov 21.
2
Prostate Artery Embolization for Giant Prostatic Hyperplasia.前列腺动脉栓塞术治疗巨大前列腺增生症
J Vasc Interv Radiol. 2015 Oct;26(10):1583-5. doi: 10.1016/j.jvir.2015.05.024.
3
Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates > 90 g: a prospective single-center study.
前列腺动脉栓塞术治疗前列腺重量>90g的良性前列腺增生症患者:一项前瞻性单中心研究
J Vasc Interv Radiol. 2015 Jan;26(1):87-93. doi: 10.1016/j.jvir.2014.10.012.
4
Giant Prostatic Hyperplasia: Fourth largest prostate reported in medical literature.巨大前列腺增生:医学文献报道的第四大前列腺病例。
Sultan Qaboos Univ Med J. 2014 May;14(2):e253-6. Epub 2014 Apr 7.
5
Prostate volume estimation using the ellipsoid formula consistently underestimates actual gland size.使用椭圆体公式估算前列腺体积一直会低估腺体的实际大小。
J Urol. 2008 Feb;179(2):501-3. doi: 10.1016/j.juro.2007.09.083.
6
Contrast-induced nephropathy.对比剂肾病
AJR Am J Roentgenol. 2004 Dec;183(6):1673-89. doi: 10.2214/ajr.183.6.01831673.
7
Benign prostatic hyperplasia.良性前列腺增生
Lancet. 2003 Apr 19;361(9366):1359-67. doi: 10.1016/S0140-6736(03)13073-5.
8
CO2 digital angiography: a safer contrast agent for renal vascular imaging?二氧化碳数字血管造影:用于肾血管成像的更安全的造影剂?
Am J Kidney Dis. 1994 Oct;24(4):685-94. doi: 10.1016/s0272-6386(12)80232-0.
9
A case of giant prostatic hyperplasia.
Urology. 1993 Sep;42(3):336-7. doi: 10.1016/0090-4295(93)90628-n.